Therapeutic agents for neurodegenerative diseases
US12144792B2 · kind B2 · utility
0Cited by
1References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 11, 2017 |
| Grant date | Nov 19, 2024 |
| Priority date | — |
| Expiry date | Aug 11, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides for treating neurodegenerative diseases comprising administering acetyl-leucine or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.